share_log

復星醫藥：海外監管公告 - 復星醫藥：募集資金存放與實際使用情況鑒證報告

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 26 08:57
Summary by Moomoo AI
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年3月26日發布海外監管公告，公告內容為該公司在上海證券交易所網站刊登的《復星醫藥：募集資金存放與實際使用情況鑒證報告》。該報告旨在提供投資者參考，並未由香港交易及結算所有限公司及香港聯合交易所有限公司對其內容準確性或完整性作出任何聲明。復星醫藥目前的執行董事包括吳以芳先生、王可心先生、關曉暉女士及文德鏞先生；非執行董事為陳啟宇先生、姚方先生、徐曉亮先生及潘東輝先生；獨立非執行董事則包括李玲女士、湯谷良先生、王全弟先生及余梓山先生。
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年3月26日發布海外監管公告，公告內容為該公司在上海證券交易所網站刊登的《復星醫藥：募集資金存放與實際使用情況鑒證報告》。該報告旨在提供投資者參考，並未由香港交易及結算所有限公司及香港聯合交易所有限公司對其內容準確性或完整性作出任何聲明。復星醫藥目前的執行董事包括吳以芳先生、王可心先生、關曉暉女士及文德鏞先生；非執行董事為陳啟宇先生、姚方先生、徐曉亮先生及潘東輝先生；獨立非執行董事則包括李玲女士、湯谷良先生、王全弟先生及余梓山先生。
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ISSUED ON 26 MARCH 2024 AN OVERSEAS REGULATORY NOTICE CONTAINING THE COMPANY'S “FUSTAR PHARMACEUTICALS: VERIFICATION OF THE STORAGE AND ACTUAL USE OF FUNDS” PUBLISHED BY THE COMPANY ON THE SHANGHAI STOCK EXCHANGE WEBSITE. The report is intended to provide investor reference and has not made any representations as to the accuracy or completeness of its contents by Hong Kong Trading and Settlement Limited and Hong Kong Stock Exchange Limited. THE CURRENT EXECUTIVE DIRECTORS OF FUSTAR PHARMACEUTICALS INCLUDE MR. WU YIFANG, MR. WANG KEXIN, MS. GUAN XIAHUI AND MR. WEN DE YUNG; THE NON-EXECUTIVE DIRECTORS ARE MR. CHEN QIYU, MR. YAO FANG, MR. XU XIAOLING AND MR. PAN TUNG HUI; THE INDEPENDENT NON-EXECUTIVE DIRECTORS INCLUDE MS. LI LING, MR. YANG GUAN LIANG, MR. WANG CHUAN AND ZHI Mr. Shan.
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ISSUED ON 26 MARCH 2024 AN OVERSEAS REGULATORY NOTICE CONTAINING THE COMPANY'S “FUSTAR PHARMACEUTICALS: VERIFICATION OF THE STORAGE AND ACTUAL USE OF FUNDS” PUBLISHED BY THE COMPANY ON THE SHANGHAI STOCK EXCHANGE WEBSITE. The report is intended to provide investor reference and has not made any representations as to the accuracy or completeness of its contents by Hong Kong Trading and Settlement Limited and Hong Kong Stock Exchange Limited. THE CURRENT EXECUTIVE DIRECTORS OF FUSTAR PHARMACEUTICALS INCLUDE MR. WU YIFANG, MR. WANG KEXIN, MS. GUAN XIAHUI AND MR. WEN DE YUNG; THE NON-EXECUTIVE DIRECTORS ARE MR. CHEN QIYU, MR. YAO FANG, MR. XU XIAOLING AND MR. PAN TUNG HUI; THE INDEPENDENT NON-EXECUTIVE DIRECTORS INCLUDE MS. LI LING, MR. YANG GUAN LIANG, MR. WANG CHUAN AND ZHI Mr. Shan.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more